An international collaborative study to establish the 1st [first] WHO international standards for C1-inhibitor, plasma and concentrate / by Craig Thelwell, Peter Rigsby and Colin Longstaff
Thelwell, Craig, Rigsby, Peter, Longstaff, Colin, World Health Organization. Biologicals Unit & WHO Expert Committee on Biological Standardization (2010 : Geneva, Switzerland). (2010). An international collaborative study to establish the 1st [first] WHO international standards for C1-inhibitor, plasma and concentrate / by Craig Thelwell, Peter Rigsby and Colin Longstaff. Geneva : World Health Organization. http://www.who.int/iris/handle/10665/70517
Gov't Doc #WHO/BS/10.2144
MetadataShow full item record
Showing items related by title and MeSH subject.
Detection of influenza B viruses with reduced sensitivity to neuraminidase inhibitor in Morocco during 2014/15 season Elfalki, F.; Ihazmad, H.; Bimouhen, A.; Regragui, Z.; Benkaroum, S.; Bakri, Y.; Barakat, A. (2016)We monitored phenotypic and genotypic susceptibility of influenza viruses circulating in Morocco during 2014-2015 to oseltamivir and zanamivir. Throat and nasal swab specimens were collected from outpatients [with influenza-like illness] and inpatients [with severe acute respiratory illness] and tested for influenza viruses using real-time reverse transcription polymerase chain reaction. Positive samples were inoculated in MDCK cells and virus phenotypic susceptibility to neuraminidase inhibitors [NAIs] was assessed using fluorescent NA inhibition. ...
Monitoring of neuraminidase inhibitor resistance among clinical influenza virus isolates in Japan during the 2003-2006 influenza seasons = Surveillance de la résistance aux inhibiteurs de la neuraminidase dans les isolements cliniques de virus grippal au Japon au cours des saisons 2003 à 2006 World Health Organization (2007)